Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease

Acta Neuropathologica

Volumn 112, Issue 4, 2006, Pages 429-437

  Woodhouse, Adele ^a   Vickers, J C James C ^a   Dickson, Tracey C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Apoptosis; Mitochondrial dysfunction; Neurofibrillary tangles; Preclinical Alzheimer's disease

Indexed keywords

CYTOCHROME C; EPITOPE; NEUROFILAMENT PROTEIN;

AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN MITOCHONDRION; BRAIN TISSUE; CELL DENSITY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE FIBER DEGENERATION; NEURITE; NEUROFIBRILLARY TANGLE; NEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN; CYTOCHROMES C; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOCORTEX; NEOPLASM PROTEINS; NEURITES; NEUROFILAMENT PROTEINS; NEURONS; TAU PROTEINS;

EID: 33749133250     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-006-0107-3     Document Type: Article

References (56)

1. Adams JM, Cory S (2001) Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26:61-66
2. Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P (2005) Cell-cycle reentry and cell death in transgenic mice expressing non-mutant human tau isoforms. J Neurosci 25:5446-5454
3. Benjelloun N, Jolly LM, Palmier B, Plotkine M, Charriaut-Marlangue C (2003) Apoptotic mitochondrial pathway in neurones and astrocytes after neonatal hypoxia-ischaemia in the rat brain. Neuropathol Appl Neurobiol 29:350-360
4. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer TA, Langui D, Duyckaerts C, Tremp G, Pradier L (2003) Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Exp Neurol 184:247-263
5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
6. Büki A, Okonkwo DO, Wang KKW, Povlishock JT (2000) Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 20:2825-2834
7. Cheung ZH, Yip HK, Wu W, So K-F (2003) Axotomy induces cytochrome c release in retinal ganglion cells. NeuroReport 14:279-282
8. Dickson TC, King CE, McCormack GH, Vickers JC (1999) Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Exp Neurol 1:100-110
9. Dickson TC, Chuckowree JA, Chuah MI, West AK, Vickers JC (2005) Novel Alzheimer's disease pathology reflects variable neuronal vulnerability and demonstrates the role of b-amyloid plaques in neurodegeneration. Neurobiol Dis 18:286-295
10. Domañksa-Janik K, Buzañska L, Dluzniewska J, Kolowska H, Sarnowska A, Zablocka B (2004) Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome c to cytoplasm. Mol Brain Res 121:50-59
11. Engidawork E, Gulesserian T, Yoo BC, Cairns N, Lubec G (2001) Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem Biophys Res Comm 281:84-93
12. Gibson GE, Haroutunian V, Zhang BM, Park LCH, Shi Q, Lesser M, Mohs RC, Sheu RK-F, Blass JP (2000) Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol 48:297-303
13. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PLR, Jones PK, Peterson RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21:3017-3023
14. Jellinger KA, Stadelmann C (2000) Mechanisms of cell death in neurodegenerative disorders. J Neural Transm Suppl 59:95-114
15. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Whitehouse PJ, Taniguchi T (1998) Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32 in Alzheimer's disease. Brain Res 780:260-269
16. Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu T, Takeda A, Nunomura A, Smith MA (2005) Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol Med 11:164-169
17. Lucassen PJ, Chung WC, Kamphorst W, Swaab DF (1997) DNA damage distribution in the human brain as shown by in situ end labelling, area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol 56:887-900
18. MacGibbon GA, Lawlor PA, Sirimanne SE, Walton MR, Connor B, Young D, Williams C, Gluckman P, Faull RLM, Hughes P, Dragunow M (1997) Bax expression in mammalian neurons undergoing apoptosis and in Alzheimer's disease hippocampus. Brain Res 750:223-234
19. Manczak M, Jung Y, Park BS, Partovi D, Reddy PH (2004) Time-course of mitochondrial gene expressions in mice brains: Implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging. J Neurochem 92:494-504
20. Martin LJ, Liu Z (2002) Injury-induced spinal motor neuron apoptosis is preceded by DNA single-strand breaks and is p53 and Bax-dependent. J Neurobiol 50:181-97
21. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R (1993) An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol 142:871-881
22. Masliah E, Sisk A, Mallory M, Games D (2001) Neurofibrillary pathology in transgenic mice overexpressing V717F b-amyloid precursor protein. J Neuropathol Exp Neurol 60:357-368
23. Mirra SS, Heyman A, McKeel D, Sumi SM, Brownlee LM, Vogel FS, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41:479-486
24. Molnár Z, Cheung AFP (2006) Towards the classification of subpopulations of layer V pyramidal projection neurons. Neurosci Res 55:105-115
25. Morris JC, Storandt M, McKeel DW, Rubin EH, Price JL, Grant EA, Berg L (1996) Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence from presymptomatic and very mild Alzheimer's disease. Neurology 46:707-719
26. Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58:188-197
27. Nagy ZS, Esiri MM (1997) Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging 18:565-571
28. Page AB, Owen CR, Kumar R, Miller JM, Rafols JA, White BC, DeGracia DJ, Krause GS (2003) Persistent elF2a(P) is co-localized with cytoplasmic cytochrome c in vulnerable hippocampal neurons after 4 hours of reperfusion following 10-minute complete brain ischemia. Acta Neuropathol 106:8-16
29. Perry G, Nunomura A, Lucassen P, Lassmann H, Smith MA (1998) Apoptosis in Alzheimer's disease. Science 282:1268-1269
30. Pollack M, Phaneuf S, Dirks A, Leeuwenburgh C (2002) The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann N Y Acad Sci 959:93-107
31. Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45:358-368
32. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomura A, Siedlak SL, Boux H, Castellani RJ, Perry G, Smith MA (2001) Abortive apoptosis in Alzheimer's disease. Acta Neuropathol 101:305-310
33. Raina AK, Hochman A, Ickes IIH, Zhu X, Ogawa O, Cash AD, Shimohama S, Perry G, Smith MA (2003) Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out? Prog Neuropsychopharmacol Biol Psychiatry 27:251-254
34. Rohn TT, Head E, Nessen WH, Cotman CE, Cribbs DH (2001) Activation of caspase-8 in the Alzheimer's disease brain. Neurobiol Dis 8:1006-1016
35. Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol Dis 11:341-354
36. SantaCruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309:476-481
37. Satou T, Cummings BJ, Cotman CW (1995) Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res 697:35-43
38. Springer JE, Azbill RD, Knapp PE (1999) Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med 5:943-946
39. Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptotsis. J Neuropathol Exp Neurol 57:456-464
40. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, Jellinger K, Lassmann H (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacular degeneration in Alzheimer's disease. Am J Pathol 155:1459-1466
41. Su JH, Satou T, Anderson AJ, Cotman CW (1996) Up-regulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease. Neuroreport 7:437-440
42. Su JH, Cummings BJ, Cotman CW (1996) Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res 739:79-87
43. Su JH, Deng G, Cotman CW (1997) Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 56:86-93
44. Su JH, Cummings BJ, Cotman CW (1998) Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites. Acta Neuropathologica 96:463-471
45. Sugaya K, Reeves M, McKinney M (1997) Topographic association between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus. Neurochem Int 31:275-281
46. Sullivan PG, Brown MR (2005) Mitochondrial aging and dysfunction in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 29:407-410
47. Tortosa A, Lopez E, Ferrer I (1998) Bcl-2 and Bax protein expression in Alzheimer's disease. Acta Neuropathol 95:407-412
48. Troncoso JC, Sukhov RR, Kawas CH, Koliatsos VE (1996) In situ labelling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. J Neuropathol Exp Neurol 55:1134-1142
49. Vickers JC, Chin D, Edwards A-M, Sampson V, Harper C, Morrison J (1996) Dystrophic neurite formation associated with age-related β-amyloid deposition in the neocortes: Clues to the genesis of neurofibrillary pathology. Exp Neurol 141:1-11
50. Vickers JC, Tan A, Dickson TC (2003) Direct determination of the proportion of intra- and extra-cellular neocortical neurofibrillary tangles in Alzheimer's disease. Brain Res 971:135-137
51. Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Catteneo E, Ferrante RJ, Kristal BS, Friedlander RM (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Hungtington's disease. PNAS 100:10483-10487
52. Wingrave JM, Schaecher KE, Sribnick EA, Wilford GG, Ray SK, Hazen-Martin DJ, Hogan EL, Banik NL (2003) Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury. J Neurosci Res 73:95-104
53. Woodhouse A, Dickson TC, West AK, McLean CA, Vickers JC (2006) No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases. Neurobiol Dis 22:323-333
54. Zhao M, Su J, Head E, Cotman CW (2003) Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease. Neurobiol Dis 14:391-401
55. Zhao H, Yenari MA, Cheng D, Sapolsky RM, Steinberg GK (2005) Biphasic cytochrome c release after transient global ischaemia and its inhibition by hypothermia. J Cereb Blood Flow Metab 25:1119-1129
56. Zhu S, Stavrovskaya IG, Drozda M, Kin BYS, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ, Przedhorski S, Kristal BS, Friedlander RM (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417:74-78